Twin Lakes Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3K | Hold |
11,557
| – | – | 0.01% | 174 |
|
|
2025
Q1 | $13.6K | Hold |
11,557
| – | – | 0.01% | 177 |
|
|
2024
Q4 | $21.1K | Sell |
11,557
-2,713
| -19% | -$4.97K | 0.01% | 177 |
|
|
2024
Q3 | $24.3K | Hold |
14,270
| – | – | 0.02% | 171 |
|
|
2024
Q2 | $19.6K | Hold |
14,270
| – | – | 0.01% | 175 |
|
|
2024
Q1 | $53.5K | Hold |
14,270
| – | – | 0.04% | 135 |
|
|
2023
Q4 | $140K | Hold |
14,270
| – | – | 0.1% | 92 |
|
|
2023
Q3 | $119K | Hold |
14,270
| – | – | 0.09% | 98 |
|
|
2023
Q2 | $190K | Hold |
14,270
| – | – | 0.13% | 85 |
|
|
2023
Q1 | $165K | Hold |
14,270
| – | – | 0.12% | 93 |
|
|
2022
Q4 | $117K | Hold |
14,270
| – | – | 0.09% | 101 |
|
|
2022
Q3 | $83K | Buy |
+14,270
| New | +$83K | 0.07% | 108 |
|
|
2022
Q2 | – | Sell |
-14,270
| Closed | -$130K | – | 243 |
|
|
2022
Q1 | $130K | Buy |
14,270
+929
| +7% | +$8.46K | 0.07% | 106 |
|
|
2021
Q4 | $273K | Hold |
13,341
| – | – | 0.15% | 86 |
|
|
2021
Q3 | $341K | Sell |
13,341
-2,454
| -16% | -$62.7K | 0.2% | 68 |
|
|
2021
Q2 | $552K | Sell |
15,795
-3,572
| -18% | -$125K | 0.31% | 53 |
|
|
2021
Q1 | $645K | Sell |
19,367
-989
| -5% | -$32.9K | 0.4% | 47 |
|
|
2020
Q4 | $528K | Buy |
+20,356
| New | +$528K | 0.38% | 54 |
|